These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22082137)

  • 1. The use of botulinum toxins for the management of chronic pain and headache: making the most of an evidence-based medicine approach for these rapidly evolving treatments.
    Argoff CE
    Pain Med; 2011 Nov; 12(11):1581-2. PubMed ID: 22082137
    [No Abstract]   [Full Text] [Related]  

  • 2. The Use of Botulinum Toxin for the Treatment of Myofascial Pain in the Masticatory Muscles.
    Laskin DM
    Oral Maxillofac Surg Clin North Am; 2018 Aug; 30(3):287-289. PubMed ID: 30008341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
    Benecke R; Heinze A; Reichel G; Hefter H; Göbel H;
    Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on botulinum toxin A injections of trigger points for myofascial pain.
    Zhou JY; Wang D
    Curr Pain Headache Rep; 2014 Jan; 18(1):386. PubMed ID: 24338700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myofascial pain.
    Malcmacher L
    Dent Today; 2013 Dec; 32(12):16. PubMed ID: 24494450
    [No Abstract]   [Full Text] [Related]  

  • 6. A critical appraisal of the evidence for botulinum toxin type A in the treatment for cervico-thoracic myofascial pain syndrome.
    Desai MJ; Shkolnikova T; Nava A; Inwald D
    Pain Pract; 2014 Feb; 14(2):185-95. PubMed ID: 23692187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review.
    Ho KY; Tan KH
    Eur J Pain; 2007 Jul; 11(5):519-27. PubMed ID: 17071119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A (BOTOX) for refractory myofascial pelvic pain.
    Adelowo A; Hacker MR; Shapiro A; Modest AM; Elkadry E
    Female Pelvic Med Reconstr Surg; 2013; 19(5):288-92. PubMed ID: 23982578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial.
    Ojala T; Arokoski JP; Partanen J
    Clin J Pain; 2006 Jan; 22(1):90-6. PubMed ID: 16340597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Botulinum toxin A for the treatment of headache disorders and pericranial pain syndromes].
    Göbel H; Heinze A; Heinze-Kuhn K; Austermann K
    Nervenarzt; 2001 Apr; 72(4):261-74. PubMed ID: 11320861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.
    Seo HG; Bang MS; Chung SG; Jung SH; Lee SU
    Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome.
    Wheeler AH; Goolkasian P; Gretz SS
    Spine (Phila Pa 1976); 1998 Aug; 23(15):1662-6; discussion 1667. PubMed ID: 9704373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of refractory pain with botulinum toxins--an evidence-based review.
    Jabbari B; Machado D
    Pain Med; 2011 Nov; 12(11):1594-606. PubMed ID: 21958302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of PrabotulinumtoxinA (Nabota
    Kim DY; Kim JM
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30177597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans.
    De Andrés J; Adsuara VM; Palmisani S; Villanueva V; López-Alarcón MD
    Reg Anesth Pain Med; 2010; 35(3):255-60. PubMed ID: 20921836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-articular knee joint Botox injection for chronic osteoarthritic pain.
    Goyal N
    Anaesth Intensive Care; 2008 Jan; 36(1):123. PubMed ID: 18326148
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of intra-articular injection of botulinum toxin type A in refractory hemiplegic shoulder pain.
    Castiglione A; Bagnato S; Boccagni C; Romano MC; Galardi G
    Arch Phys Med Rehabil; 2011 Jul; 92(7):1034-7. PubMed ID: 21704782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A therapy in chronic pain disorders.
    Lang AM
    Arch Phys Med Rehabil; 2003 Mar; 84(3 Suppl 1):S69-73; quiz S74-5. PubMed ID: 12708561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type A in refractory chronic migraine: an open-label trial.
    Menezes C; Rodrigues B; Magalhães E; Melo A
    Arq Neuropsiquiatr; 2007 Sep; 65(3A):596-8. PubMed ID: 17876397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Efficacy of Botulinum Toxin, Local Anesthesia, and Platelet-Rich Plasma Injections in Patients With Myofascial Trigger Points in the Masseter Muscle.
    Yilmaz O; Sivrikaya EC; Taskesen F; Pirpir C; Ciftci S
    J Oral Maxillofac Surg; 2021 Jan; 79(1):88.e1-88.e9. PubMed ID: 33045182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.